Fullscript Dr. Christopher Knee, ND, MSc headshot

Fullscript Collective
Dr. Christopher Knee, ND, MSc

Research and Education Manager - Fullscript

Dr. Christopher Knee is a naturopathic doctor, clinical researcher, and natural health and wellness expert from Ottawa, Canada. As Research and Education Manager for Fullscript’s Integrative Medical Advisory Team (IMAT), he oversees research curation projects and the development of educational content for practitioners and patients across North America.

He completed Bachelor and Master of Science degrees from the University of Guelph, in Human Kinetics and Human Biology/Nutritional Sciences, respectively, and completed naturopathic training at the Canadian College of Naturopathic Medicine. He is passionate about evidence-informed practice, patient education, health services research, and advancing our understanding of natural medicines. He has extensive industry and advisory experience, having worked with various organizations including The Ottawa Hospital, Ottawa Police Service, University of Ottawa Heart Institute, Ontario Association of Naturopathic Doctors, Valeant Pharmaceuticals, MDS Nordion, and Pfizer Inc.

More members of the Collective

Dr. Tieraona Low Dog, MD

Former Fellowship Director, University of Arizona’s Center for Integrative Medicine

Dr. Tieraona Low Dog’s exploration of natural medicine began mo...

Dr. Jeffrey Bland, PhD, FACN, FACB, CNS

Founder, Institute for Functional Medicine

Dr. Jeffrey Bland has been an internationally recognized leader i...

Dr. Joseph Pizzorno, ND

Chairman of the Board, Institute for Functional Medicine

Dr. Joseph Pizzorno is a naturopathic physician, educator, and re...

Dr. Robin Berzin, MD

Founder, Parsley Health

Dr. Robin Berzin, MD is the founder and CEO of Parsley Health. A ...

Dr. Cheng Ruan, MD

Founder, Texas Center for Functional Medicine

Dr. Cheng Ruan, MD, is board-certified in internal medicine and t...

Dr. Jeffrey Gladd, MD

Chair, Fullscript Medical Advisory Board

As Chief Medical Officer, Dr. Jeffrey Gladd advises on company an...